Modified Valsalva maneuver for treatment of supraventricular tachycardias: A Meta-analysis

Efficacy and safety of modified Valsalva maneuver for treatment of paroxysmal supraventricular tachycardia: a meta-analysis

OBJECTIVE

To compare the efficacy and safety of the modified versus standard Valsalva maneuver in the treatment of paroxysmal supraventricular tachycardia (PSVT).

METHODS

The PubMed, Embase, Web of Science, CNKI, WanFang Data, and VIP electronic databases were searched to identify studies comparing the modified and standard Valsalva maneuvers in the treatment of PSVT from database inception to 1 May 2023. Two reviewers independently screened the literature, extracted the data, and assessed the risk of bias of all included studies.

RESULTS

Nineteen randomized controlled trials involving 2527 patients with PSVT were included. The overall rate of cardioversion was higher in the modified than standard Valsalva group (risk ratio [RR] = 1.80, 95% confidence interval [CI] = 1.61-2.01), as was the success rate of cardioversion after a single Valsalva maneuver (RR = 2.05, 95% CI = 1.74-2.41). There was no statistically significant difference in adverse reactions between the two groups (RR = 1.07, 95% CI = 0.82-1.38).

CONCLUSION

Current evidence suggests that the modified Valsalva maneuver can significantly improve the success rate of cardioversion in patients with PSVT without increasing adverse reactions. The modified Valsalva maneuver is therefore worth promoting and should be considered as a routine first treatment.INPLASY registration number: 2023100092.

Forced inspiratory suction and swallow tool (FISST): an automation of Valsalva maneuver variants for therapeutic interventions

INTRODUCTION

The Valsalva maneuver and its modifications have been utilized across several conditions in medicine; however, there have been difficulties in its application. Thus, at the University of Texas Health Science Center in San Antonio, we designed and patented an affordable and accessible device that mimics Valsalva called "Forced Inspiratory Suction and Swallow Tool (FISST).

AREAS COVERED

In this review, we discuss the premise for the design of FISST, based on applications of the law of conservation energy, the continuity equation, and Bernoulli's principle. We then detail the mechanism by which FISST stimulates hiccup cessation by increasing negative inspiratory pressure when drinking through the apparatus, causing diaphragmatic contraction and disruption of the hiccup reflex. We then detail the efficacy and future applications of FISST in addressing other pathologies.

EXPERT OPINION

FISST has been used to address hiccups by utilizing its reverse-Valsalva effect to increase parasympathetic stimulation by increasing vagal tone. In a prospective study that we conducted on a cohort of 249 hiccup subjects worldwide, this tool achieved 92% effectiveness. Additionally, several cases, including a published case report, have found FISST successful in terminating supraventricular tachycardias (SVT). FISST may be further utilized in diagnosing or addressing various upper airway pathologies and should be explored further.

Effect of Valsalva Maneuver on Choriocapillary Retinal Microvasculature

PURPOSE

We aimed to identify and evaluate possible quantitative changes in retinal and choriocapillary blood flow utilizing optical coherence tomography angiography (OCTA) imaging in healthy study subjects during the Valsalva maneuver (VM).

METHODS

OCTA imaging with a ZEISS PlexElite 9000 on one eye was performed. OCTA images were acquired before VM and 5 seconds after. Images were segmented and underwent projection removal using algorithms supplied by the manufacturer. Analysis of vessel density (VD) and vessel length density (VLD) were performed on superficial (SCP) and deep capillary plexus (DCP) layer slabs using ImageJ. ImageJ was also utilized for analyzing flow voids (FVs) in the choriocapillary slabs.

RESULTS

Ten (8 right, 2 left) eyes of 10 (5 male, 5 female) healthy study subjects were included. Pre-VM, -VD, and -VLD were 0.428 (± 0.291) and 17.871 mm^-1 (± 2.22 mm^-1) in the SCP and 0.423 (± 0.0213) and 23.850 mm^-1 (± 1.023 mm^-1) in the DCP. Pre-VM and -FV were measured at 19.686 (± 1.959). During VM, VD, and VLD in the SCP were 0.417 (± 0.024) and 17.376 mm^-1 (± 2.007 mm^-1), and in the DCP, 0.426 (± 0.221) and 23.944 mm^-1 (± 1.021 mm^-1), respectively. FV post-VM was 20.440 (± 2.062). A paired samples t-test test revealed no significant changes in any of the observed parameters.

CONCLUSION

We did not observe any significant changes in the VD, VLD, or FV. This might be due to autoregulatory processes in the ocular vasculature. Due to the small sample size, confidence intervals are comparatively large. Further study with more probands might yield different results.